Matches in Wikidata for { <http://www.wikidata.org/entity/Q86845291> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q86845291 description "artículu científicu espublizáu en marzu de 2015" @default.
- Q86845291 description "scientific article published on 01 March 2015" @default.
- Q86845291 description "wetenschappelijk artikel" @default.
- Q86845291 description "наукова стаття, опублікована в березні 2015" @default.
- Q86845291 description "գիտական հոդված հրատարակված 2015 թվականի մարտի 1-ին" @default.
- Q86845291 name "Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis" @default.
- Q86845291 name "Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis" @default.
- Q86845291 type Item @default.
- Q86845291 label "Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis" @default.
- Q86845291 label "Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis" @default.
- Q86845291 prefLabel "Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis" @default.
- Q86845291 prefLabel "Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis" @default.
- Q86845291 P1433 Q86845291-43F537A2-518F-4379-B416-0F06CE89675D @default.
- Q86845291 P1476 Q86845291-1AC42343-A067-4044-B13A-F759142B3AA0 @default.
- Q86845291 P2093 Q86845291-2F10B4E1-DBDD-48AA-BFEB-75E691D7CB21 @default.
- Q86845291 P2093 Q86845291-3E19AC05-D0D3-4AE6-A8C5-81B3EF6EA52D @default.
- Q86845291 P2093 Q86845291-49CAFFFF-A7D9-4D54-A270-33FECDC8BC5E @default.
- Q86845291 P2093 Q86845291-76871A58-8DD2-43CA-ADDA-48049993FC9E @default.
- Q86845291 P2093 Q86845291-B9B10C6A-6749-4869-8147-57A2570B8A96 @default.
- Q86845291 P2093 Q86845291-C3CBF58F-6571-4072-A40D-D613374DB0F5 @default.
- Q86845291 P304 Q86845291-54744EF2-C7DB-411C-BC51-74429F2D2C83 @default.
- Q86845291 P31 Q86845291-B13DC8C1-6DCD-4621-9AD8-EC9A4359868B @default.
- Q86845291 P356 Q86845291-049AD1FF-7E65-421F-88D3-11BA6D01E13C @default.
- Q86845291 P433 Q86845291-C018CA1C-06C2-469D-AB76-C89337F4DCDF @default.
- Q86845291 P478 Q86845291-2C51B732-056F-44D3-8044-9196B2C161AA @default.
- Q86845291 P577 Q86845291-C1A31B2F-3D07-46CA-9ECB-79C9F3F0D02C @default.
- Q86845291 P698 Q86845291-3F32F850-17AA-4847-9AA3-33DE555DD10A @default.
- Q86845291 P921 Q86845291-EA482A34-759C-47FC-83F5-F1742A9259C0 @default.
- Q86845291 P356 JMCP.2015.21.3.201 @default.
- Q86845291 P698 25726029 @default.
- Q86845291 P1433 Q23894211 @default.
- Q86845291 P1476 "Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis" @default.
- Q86845291 P2093 "Howard S Friedman" @default.
- Q86845291 P2093 "Jackie Lu" @default.
- Q86845291 P2093 "Mary Helen Tran" @default.
- Q86845291 P2093 "Prakash Navaratnam" @default.
- Q86845291 P2093 "Steven R Feldman" @default.
- Q86845291 P2093 "Yang Zhao" @default.
- Q86845291 P304 "201-209" @default.
- Q86845291 P31 Q13442814 @default.
- Q86845291 P356 "10.18553/JMCP.2015.21.3.201" @default.
- Q86845291 P433 "3" @default.
- Q86845291 P478 "21" @default.
- Q86845291 P577 "2015-03-01T00:00:00Z" @default.
- Q86845291 P698 "25726029" @default.
- Q86845291 P921 Q348260 @default.